Congressionally Directed Medical Research Programs -- Peer Reviewed Alzheimer’s Disease Research Program -- Research Partnership Award

Funding Agency:
Department of Defense

The PRARP Research Partnership Award (RPA) mechanism is being offered for the first time in FY17.

The intent of the RPA is to create an avenue for collaborative research partnerships between investigators to address a research problem or question in a manner that would be unachievable through separate efforts. In addition to supporting basic research, applications proposing preclinical research are acceptable under this mechanism. 

The FY17 PRARP RPA is open to Principal Investigators (PIs) at or above the level of Assistant Professor (or equivalent) from any field or discipline. The FY17 PRARP RPA requires that two investigators (i.e., partners) jointly design a single research project. It should be clear that each partner had equal intellectual input into the design of the research project. Either partner may submit as the PI; the other partner will be designated as the Co-PI. Multi-institutional research is encouraged but not required. 

Deadlines:

  • REQUIRED Pre-application Submission Deadline:  September 21, 2017 (was September 6, 2017)
  • Full Application Submission Deadline:  October 5, 2017 (was September 20, 2017)

Agency Website

Areas of Interest

FY17 PRARP RPA Overarching Challenges: This FY17 PRARP RPA funding opportunity requires applications to address one or more of the following FY17 PRARP RPA Overarching Challenges:

• Paucity of Research Resources: The paucity of research resources to examine the interrelationship between TBI and subsequent AD/ADRD for the military, Veteran, and civilian communities.

• Paucity of Clinical Studies: The paucity of clinical studies to examine the interrelationship between TBI and subsequent AD/ADRD for the military, Veteran, and civilian communities. This includes research into risk factors that may predispose individuals to AD/ADRD subsequent to TBI.

• Diagnostic Technologies, Tests, Biomarkers, or Devices: The need for technologies, tests, or devices to detect or prognose the progression to AD/ADRD subsequent to TBI. This includes research into risk factors that may predispose individuals to AD/ADRD subsequent to TBI.

• Quality of Life: The need for technologies, assessments, interventions, or devices to benefit individuals living with the common symptoms or deficits of TBI and AD/ADRD. 

• Caregiver Burden: The need for technologies, assessments, interventions, or devices with the goal of reducing burden for caregivers of individuals living with the common symptoms or deficits of TBI and AD/ADRD.

• Epidemiology: The paucity of epidemiological research to examine the interrelationship between TBI and subsequent AD/ADRD for the military, Veteran, and civilian communities. This includes research into risk factors that may predispose individuals to AD/ADRD subsequent to TBI.

 

Eligibility Requirements

Each PI must be an independent investigator at or above the level of Assistant Professor (or equivalent). 

Amount

$1,300,000

Amount Description

The anticipated total costs budgeted for the entire period of performance for an FY17 PRARP RPA will not exceed $1,300,000. The maximum period of performance is 3 years. Refer to Section II.D.5, Funding Restrictions, for detailed funding information. 

Funding Type

Grant

Eligibility

Faculty
Junior Faculty

Category

Engineering and Physical Sciences
Interdisciplinary
Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

September 21, 2017